Please login to the form below

Not currently logged in
Email:
Password:

Ranbaxy launches generic version of AZ drug

Ranbaxy Pharmaceuticals in agreement with AstraZeneca (AZ) has launched a generic version of Prilosec in the US
Ranbaxy Pharmaceuticals in agreement with AstraZeneca (AZ) has launched a generic version of Prilosec in the US.

Prilosec, a treatment for conditions caused by excess stomach acid, was originally developed and marketed by AZ and experienced sales in the US of $204.2m, according to IMS data cited by Ranbaxy. Under the terms of the new agreement Ranbaxy Pharmaceuticals - a wholly owned subsidiary of India's largest pharma company, Ranbaxy Laboratories - will begin manufacturing the drug using its generic name, omeprazole.

"We welcome the opportunity to market an authorised generic of omeprazole 40mg capsules that will be commercialised immediately to all classes of trade in the US healthcare system under the Ranbaxy label," said Jim Meehan, vice-president of sales and distribution for RPI.

RPI is based in Florida and markets products to the US healthcare system.

28th July 2008

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Complete HealthVizion

Complete HealthVizion is a global team of fresh thinkers who aspire to be better every day. We create life-changing medical...

Latest intelligence

Is the pharma business model ready for precision medicine?
Precision medicine promises to revolutionise patient outcomes and reduce costs for industry but is pharma ready for it? Blue Latitude Health co-founder Head of Strategy Fred Bassett explores the challenges...
ABPI2018
The NHS and ABPI at 70: inching closer to the triple win
The NHS and UK pharma’s ABPI both turn 70 this year. After years of transactional relationships, there’s a will to work more closely - but friction on prices and value...
What pharma marketers can learn from behavioural science
Pharma behavioural science and traditional emotional marketing create a powerful mix of techniques that have impact on real lives....

Infographics